Your browser doesn't support javascript.
loading
Identification of BRCA2 Cis Double Heterozygous Breast Cancer Cases Using Whole Exome Sequencing: Phenotypic Expression and Impact on Personalized Oncology.
Hamdi, Yosr; Boujemaa, Maroua; Mighri, Najah; Mejri, Nesrine; Jaidane, Olfa; Ben Nasr, Sonia; Bouaziz, Hanen; Hassouna, Jamel Ben; Zribi, Aref; Berrazaga, Yossra; Rachdi, Haifa; Daoud, Nouha; El Benna, Houda; Labidi, Soumaya; Haddaoui, Abderrazek; Rahal, Khaled; Benna, Farouk; Boussen, Hamouda; Abdelhak, Sonia; Boubaker, Samir.
Afiliação
  • Hamdi Y; Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Boujemaa M; Laboratory of Human and Experimental Pathology, Institut Pasteur de Tunis, Tunis, Tunisia.
  • Mighri N; Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Mejri N; Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Jaidane O; Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Ben Nasr S; Medical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
  • Bouaziz H; Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia.
  • Hassouna JB; Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Zribi A; Department of Medical Oncology, Military Hospital, Tunis, Tunisia.
  • Berrazaga Y; Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Rachdi H; Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia.
  • Daoud N; Surgical Oncology Department, Salah Azaiez Institute of Cancer, Tunis, Tunisia.
  • El Benna H; Department of Medical Oncology, Military Hospital, Tunis, Tunisia.
  • Labidi S; Medical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
  • Haddaoui A; Medical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
  • Rahal K; Medical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
  • Benna F; Medical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
  • Boussen H; Laboratory of Biomedical Genomics and Oncogenetics, LR20IPT05, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Abdelhak S; Medical Oncology Department, Abderrahmen Mami Hospital, Ariana, Tunisia.
  • Boubaker S; Department of Medical Oncology, Military Hospital, Tunis, Tunisia.
Front Genet ; 12: 674990, 2021.
Article em En | MEDLINE | ID: mdl-34456966
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Tunísia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Tunísia